Compounded products are also different from FDA-approved medications , and quality can vary
Employer Responses: To manage costs, employers are more likely to reduce coverage or shift costs to employees, with 56% of large employers planning cost-cutting measures for 2026 compared to 48% in 2025
Third-party testing transparency Whether independent laboratory testing is provided, how accessible it is, and how clearly results are presented
Seriously, avoid scratching
Furthermore, while the roles of GGT and ChaC1/ChaC2 in tumor tissue are known, these enzymes represent only the initial steps in GSH degradation
More time and clinical studies are needed to determine whatever long-term health benefits and cost avoidance result from prescribing and covering these drugs for weight loss